Search Results
MedRN: Melanoma (Topic)

173 Total downloads

Viewing: 1 - 9 of 9 papers

1.

Estimating Clinical Trial Success Rates and Related Parameters in Oncology

Number of pages: 20 Posted: 14 Apr 2019 Last Revised: 09 May 2019
Working Paper Series
Massachusetts Institute of Technology (MIT) - Computer Science and Artificial Intelligence Laboratory (CSAIL), Massachusetts Institute of Technology (MIT) and Massachusetts Institute of Technology (MIT) - Sloan School of Management
Downloads 73
2.

Epacadostat Plus Pembrolizumab versus Placebo Plus Pembrolizumab in Patients with Unresectable or Metastatic Melanoma: Results of the Phase 3, Randomised, Double-Blind Echo-301/Keynote-252 Study

Number of pages: 39 Posted: 05 Feb 2019
Working Paper Series
The University of Sydney - Melanoma Institute Australia, University Hospital Zurich, Angeles Clinic and Research Institute, University of Chicago - Medical Center, Universidad del Desarrollo - Facultad de Medicina Clínica Alemana, University of Lyon 1, Hospital Clinic of Barcelona, The University of Sydney - Melanoma Institute Australia, Aix-Marseille University, Seoul National University - Seoul National Hospital, N.N. Blokhin Russian Cancer Research Center, Université Paris XI Sud - Gustave Roussy Cancer Campus, Royal Marsden NHS Foundation Trust, Merck & Co., Inc., Incyte Corporation, Incyte Corporation, Merck & Co., Inc. and University of Pennsylvania, Perelman School of Medicine, Abramson Family Cancer Research Institute
Downloads 30
3.

Sensitive, Non‐Destructive Detection and Analysis of Neoantigen‐Specific T Cell Populations from Tumors and Blood

Number of pages: 47 Posted: 12 Apr 2018
Working Paper Series
California Institute of Technology - Division of Chemistry and Chemical Engineering, University of California, Los Angeles (UCLA) - Department of Medicine, California Institute of Technology - Division of Biology and Biological Engineering, California Institute of Technology - Division of Biology and Biological Engineering, California Institute of Technology - Division of Chemistry and Chemical Engineering, California Institute of Technology - Division of Chemistry and Chemical Engineering, California Institute of Technology - Division of Biology and Biological Engineering, California Institute of Technology - Division of Chemistry and Chemical Engineering, California Institute of Technology - Division of Chemistry and Chemical Engineering, California Institute of Technology - Division of Chemistry and Chemical Engineering, California Institute of Technology - Division of Biology and Biological Engineering, California Institute of Technology - Division of Chemistry and Chemical Engineering, California Institute of Technology - Division of Chemistry and Chemical Engineering, University of California, Los Angeles (UCLA) - Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles (UCLA) - Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles (UCLA) - Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, California Institute of Technology - Division of Biology and Biological Engineering, University of California, Los Angeles (UCLA) - Department of Medicine and California Institute of Technology - Division of Chemistry and Chemical Engineering
Downloads 27
4.

Axitinib in Combination with Toripalimab, a Humanized IgG4 mAb Against Programmed Death-1 (PD-1) in Patients with Metastatic Mucosal Melanoma: A Non-Randomized, Open-Label, Dose-Finding, and Cohort-Expansion Phase 1b Trial

Number of pages: 148 Posted: 24 Jan 2019
Working Paper Series
Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, OrigiMed, Shanghai Junshi Biosciences Co., LTD, Shanghai Junshi Biosciences Co., LTD, Shanghai Junshi Biosciences Co., LTD, Shanghai Junshi Biosciences Co., LTD, Shanghai Junshi Biosciences Co., LTD, Harvard University - Harvard Medical School and Peking University - Key Laboratory of Carcinogenesis and Translational Research
Downloads 21
5.

In Situ Transfection of Interleukin 12 Plasmid Enhances Anti-PD-1 Immune Response in Patients with Immunologically Quiescent Melanoma

Number of pages: 37 Posted: 05 Mar 2019
Working Paper Series
University of California, San Francisco (UCSF) - Department of Medicine, OncoSec Inc, University of California, San Francisco (UCSF) - Department of Medicine, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, OncoSec Inc, OncoSec Inc, OncoSec Inc, OncoSec Inc, University of California, San Francisco (UCSF) - Department of Medicine, OncoSec Inc, University of California, San Francisco (UCSF) - Department of Medicine, Massachusetts General Hospital - Center for Systems Biology, Massachusetts General Hospital - Center for Systems Biology, Massachusetts General Hospital - Center for Systems Biology, OncoSec Inc, University of California, San Francisco (UCSF) - Department of Medicine, University of California, San Francisco (UCSF) - Department of Medicine, Fred Hutchinson Cancer Research Center, Merck & Co., Inc., Huntsman Cancer Institute, Providence Cancer Center - Earle A. Chiles Research Institute, University of California, San Francisco (UCSF) - Department of Dermatology and University of California, San Francisco (UCSF) - Department of Medicine
Downloads 8
6.

Salinomycin Effectively Eliminates Cancer Stem-Like Cells and Obviates Hepatic Metastasis in Uveal Melanoma

Number of pages: 44 Posted: 28 Jan 2019
Working Paper Series
Sun Yat-Sen University (SYSU) - State Key Laboratory of Ophthalmology, Sun Yat-Sen University (SYSU) - State Key Laboratory of Ophthalmology, Sun Yat-Sen University (SYSU) - State Key Laboratory of Ophthalmology, Sun Yat-Sen University (SYSU) - State Key Laboratory of Ophthalmology, Sun Yat-Sen University (SYSU) - State Key Laboratory of Ophthalmology, Sun Yat-Sen University (SYSU) - State Key Laboratory of Ophthalmology and Sun Yat-Sen University (SYSU) - State Key Laboratory of Ophthalmology
Downloads 6
7.

Melanoma Therapeutic Strategies That Select Against Resistance by Exploiting MYC-Driven Evolutionary Convergence

Number of pages: 79 Posted: 06 Apr 2018
Working Paper Series
Duke University - Department of Pharmacology and Cancer Biology, Duke University - Department of Statistical Science, Duke University - Department of Pharmacology and Cancer Biology, Harvard University, Harvard Medical School, Brigham and Women's Hospital, Department of Medicine, Genetics Division, Harvard University, Harvard Medical School, Brigham and Women's Hospital, Department of Medicine, Genetics Division, Duke University - Department of Pharmacology and Cancer Biology, Duke University - Department of Pharmacology and Cancer Biology, Case Western Reserve University, School of Medicine, Department of Genetics and Genome Sciences, Duke University - Department of Pharmacology and Cancer Biology, Duke University - Department of Pharmacology and Cancer Biology, Harvard University - Harvard Medical School, Harvard University - Harvard Medical School, Harvard University - Harvard Medical School, Duke University, School of Medicine, Department of Pathology, University of Pennsylvania, The Wistar Institute of Anatomy and Biology, Molecular and Cellular Oncogenesis Program, University of Pennsylvania, The Wistar Institute of Anatomy and Biology, Molecular and Cellular Oncogenesis Program, University of Pennsylvania, The Wistar Institute of Anatomy and Biology, Molecular and Cellular Oncogenesis Program, Case Western Reserve University, School of Medicine, Department of Genetics and Genome Sciences, Duke University - Department of Pharmacology and Cancer Biology, Harvard University, Harvard Medical School, Brigham and Women's Hospital, Department of Medicine, Genetics Division, Duke University - Department of Statistical Science and Duke University - Department of Pharmacology and Cancer Biology
Downloads 4
8.

A New Modified Kohenon Algorithm for Automatic Skin Cancer Detection

Number of pages: 6 Posted: 07 Aug 2019
Working Paper Series
Sri Chandrasekharendra Saraswathi Viswa Mahavidyalaya University (SCSVMV), Students and C.Abdul Hakeem College of Engineering &Technology
Downloads 2
9.

Computer Aided Segmentation Approach for Melanoma Skin Cancer Detection

Number of pages: 4 Posted: 04 Jun 2019
Working Paper Series
South Eastern University of Sri Lanka and affiliation not provided to SSRN
Downloads 2